Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-009282
Filing Date
2026-02-18
Accepted
2026-02-18 17:43:44
Documents
1
Period of Report
2026-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771454620.html 4  
1 FORM 4 wk-form4_1771454620.xml 4 5143
  Complete submission text file 0001628280-26-009282.txt   6582
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 430 MOUNTAIN AVE. SUITE 404 NEW PROVIDENCE NJ 07974
Business Address
Zaki Mohamed (Reporting) CIK: 0002000697 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 26650507